Please login to the form below

AMR

This page shows the latest AMR news and features for those working in and with pharma, biotech and healthcare.

Perfect partners

Everything from developing vaccines in months rather than years, CEOs’ partnering in open letters reaffirming safety before speed, 20 biopharmaceutical companies creating the AMR Action Fund to bring new antibiotics to

Latest news

UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

In the UK, over 5, 000 deaths per year are attributed to antimicrobial resistance (AMR), with over 25, 000 deaths per year attributed to AMR in the EU. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a
MSD launches antibiotic combo Recarbrio in UK

The aptly named AMR Action Fund is aiming to bring two to four new antibiotics to patients by 2030. ... Current reimbursement frameworks simply do not support the level of sustained R&D investment that is needed to tackle AMR.
Shionogi’s novel antibiotic trial data published in The Lancet

In the UK, over 5, 000 deaths per year are attributed to antimicrobial resistance (AMR), with over 25, 000 death per year attributed to AMR in the EU. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a
Shionogi's Gram-negative antibiotic launches in the UK

AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a range of antimicrobial drugs, such as antibiotics, antifungals and antivirals. ... WHO stands ready to support the AMR Action Fund in its focus on public
Novartis’ Sandoz division announces antibiotic manufacturing plan

Earlier this month, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) raised nearly $1bn to support clinical research into new antibiotics in a bid to tackle growing antimicrobial resistance (AMR).

More from news
Approximately 9 fully matching, plus 24 partially matching documents found.

Latest Intelligence

Rethinking our approach to infectious disease preparedness

my view, virtually non-existent, but this has been the model in the AMR sector for the past few years. ... Peter Jackson, executive director, Infex Therapeutics (previously the AMR Centre). 24th November 2020.
How COVID-19 is accelerating the threat of antimicrobial resistance

The World Health Organization (WHO) states that antimicrobial resistance (AMR) is a global concern. ... A pharmacist in the UK echoed this sentiment, expressing that he could not sense the urgency about AMR right now.
The global antibiotic crisis: a 2020 perspective

market reform to address the payment problem at the heart of the AMR sector. ... saving AMR drugs sparingly to avoid widespread emergence of new drug-resistant infections.
Tackling antimicrobial resistance on multiple fronts

An urgent change of direction is needed in how we respond to AMR. ... Why not an international AMR Fund to support uptake of products to tackle AMR too?
Combining therapies and combining research

The strategy for retaining antibiotic security. The World Health Organization recognises antimicrobial resistance (AMR) as one of the most pressing global threats to medicine. ... Antimicrobial resistance (AMR) is a complex issue of global concern that

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

Antibiotic resistance: The silent pandemic

Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894/UK_AMR_5_year_national_action_plan.pdf. Accessed November 2019. Health Europa. Rapid diagnostic
Mobilising the public to combat the antimicrobial resistance crisis

Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think. ... Meaning close to a quarter of patients gain no medical benefit from antibiotics – they merely contribute to increased AMR.
Antibiotic Resistance: Alarm bells ring louder than ever

where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... How can this be prevented? AMR is a complex, global issue and corrective action is only possible if we accurately know and understand what
amr

amr is a full-service market research agency and we are passionate about the research that we do.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Lead Copywriter: Competitive

Healthcare Account Director: Competitive

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Account Director – Creative Healthcare Communications: Competative

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Senior Account Manager: Competitive

PMHub

Add my company

Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...